Page last updated: 2024-08-25

nsc 361456 and Neoplasms

nsc 361456 has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ames, MM; Dhodapkar, MV; Reid, JM; Richardson, RL1
Balcerzak, SP; Kraut, EH; Supko, JG1

Trials

2 trial(s) available for nsc 361456 and Neoplasms

ArticleYear
Pyrazine diazohydroxide (NSC-361456). Phase I clinical and pharmacokinetic studies.
    Investigational new drugs, 1994, Volume: 12, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Drug Tolerance; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Pyrazines

1994
Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors.
    Cancer research, 1993, Oct-15, Volume: 53, Issue:20

    Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Neoplasms; Pyrazines

1993